Log In
Print this Print this

dexketoprofen trometamol/tramadol hydrochloride

  Manage Alerts
Collapse Summary General Information
Company Menarini Group
DescriptionFixed dose combination of dexketoprofen trometamol and tramadol hydrochloride
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist; NSAID
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe acute pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today